vs
Acadia Healthcare Company, Inc.（ACHC）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是RBC Bearings INC的1.8倍（$821.5M vs $461.6M），RBC Bearings INC净利率更高（14.6% vs -143.3%，领先157.9%），RBC Bearings INC同比增速更快（17.0% vs 6.1%），RBC Bearings INC自由现金流更多（$99.1M vs $-179.5M），过去两年RBC Bearings INC的营收复合增速更高（5.6% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
ACHC vs RBC — 直观对比
营收规模更大
ACHC
是对方的1.8倍
$461.6M
营收增速更快
RBC
高出10.9%
6.1%
净利率更高
RBC
高出157.9%
-143.3%
自由现金流更多
RBC
多$278.6M
$-179.5M
两年增速更快
RBC
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $461.6M |
| 净利润 | $-1.2B | $67.4M |
| 毛利率 | — | 44.3% |
| 营业利润率 | -142.4% | 22.3% |
| 净利率 | -143.3% | 14.6% |
| 营收同比 | 6.1% | 17.0% |
| 净利润同比 | -3710.4% | 16.4% |
| 每股收益（稀释后） | $-12.98 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCRBC
| Q4 25 | $821.5M | $461.6M | ||
| Q3 25 | $851.6M | $455.3M | ||
| Q2 25 | $869.2M | $436.0M | ||
| Q1 25 | $770.5M | $437.7M | ||
| Q4 24 | $774.2M | $394.4M | ||
| Q3 24 | $815.6M | $397.9M | ||
| Q2 24 | $796.0M | $406.3M | ||
| Q1 24 | $768.1M | $413.7M |
净利润ACHCRBC
| Q4 25 | $-1.2B | $67.4M | ||
| Q3 25 | $36.2M | $60.0M | ||
| Q2 25 | $30.1M | $68.5M | ||
| Q1 25 | $8.4M | $72.7M | ||
| Q4 24 | $32.6M | $57.9M | ||
| Q3 24 | $68.1M | $54.2M | ||
| Q2 24 | $78.5M | $61.4M | ||
| Q1 24 | $76.4M | — |
毛利率ACHCRBC
| Q4 25 | — | 44.3% | ||
| Q3 25 | — | 44.1% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | 44.3% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 45.3% | ||
| Q1 24 | — | 43.1% |
营业利润率ACHCRBC
| Q4 25 | -142.4% | 22.3% | ||
| Q3 25 | 4.7% | 21.5% | ||
| Q2 25 | 5.8% | 23.2% | ||
| Q1 25 | 1.7% | 23.0% | ||
| Q4 24 | 4.9% | 21.7% | ||
| Q3 24 | 12.1% | 21.6% | ||
| Q2 24 | 13.4% | 24.0% | ||
| Q1 24 | 12.9% | 22.8% |
净利率ACHCRBC
| Q4 25 | -143.3% | 14.6% | ||
| Q3 25 | 4.3% | 13.2% | ||
| Q2 25 | 3.5% | 15.7% | ||
| Q1 25 | 1.1% | 16.6% | ||
| Q4 24 | 4.2% | 14.7% | ||
| Q3 24 | 8.4% | 13.6% | ||
| Q2 24 | 9.9% | 15.1% | ||
| Q1 24 | 9.9% | — |
每股收益（稀释后）ACHCRBC
| Q4 25 | $-12.98 | $2.13 | ||
| Q3 25 | $0.40 | $1.90 | ||
| Q2 25 | $0.33 | $2.17 | ||
| Q1 25 | $0.09 | $2.33 | ||
| Q4 24 | $0.36 | $1.82 | ||
| Q3 24 | $0.74 | $1.65 | ||
| Q2 24 | $0.85 | $1.90 | ||
| Q1 24 | $0.83 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $107.6M |
| 总债务越低越好 | $2.5B | $990.2M |
| 股东权益账面价值 | $1.9B | $3.3B |
| 总资产 | $5.5B | $5.1B |
| 负债/权益比越低杠杆越低 | 1.28× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ACHCRBC
| Q4 25 | $133.2M | $107.6M | ||
| Q3 25 | $118.7M | $91.2M | ||
| Q2 25 | $131.4M | $132.9M | ||
| Q1 25 | $91.2M | $36.8M | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | $76.8M | ||
| Q1 24 | $77.3M | $63.5M |
总债务ACHCRBC
| Q4 25 | $2.5B | $990.2M | ||
| Q3 25 | $2.3B | $1.1B | ||
| Q2 25 | $2.3B | $915.6M | ||
| Q1 25 | $2.2B | $920.1M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | $1.2B |
股东权益ACHCRBC
| Q4 25 | $1.9B | $3.3B | ||
| Q3 25 | $3.1B | $3.2B | ||
| Q2 25 | $3.1B | $3.1B | ||
| Q1 25 | $3.0B | $3.0B | ||
| Q4 24 | $3.1B | $2.9B | ||
| Q3 24 | $3.0B | $2.9B | ||
| Q2 24 | $3.0B | $2.8B | ||
| Q1 24 | $2.9B | $2.8B |
总资产ACHCRBC
| Q4 25 | $5.5B | $5.1B | ||
| Q3 25 | $6.4B | $5.1B | ||
| Q2 25 | $6.3B | $4.8B | ||
| Q1 25 | $6.1B | $4.7B | ||
| Q4 24 | $6.0B | $4.7B | ||
| Q3 24 | $5.9B | $4.7B | ||
| Q2 24 | $5.7B | $4.7B | ||
| Q1 24 | $5.5B | $4.7B |
负债/权益比ACHCRBC
| Q4 25 | 1.28× | 0.30× | ||
| Q3 25 | 0.74× | 0.34× | ||
| Q2 25 | 0.74× | 0.29× | ||
| Q1 25 | 0.72× | 0.30× | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $99.1M |
| 自由现金流率自由现金流/营收 | -21.8% | 21.5% |
| 资本支出强度资本支出/营收 | 11.3% | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | — |
8季度趋势，按日历期对齐
经营现金流ACHCRBC
| Q4 25 | $-86.3M | $122.1M | ||
| Q3 25 | $73.2M | $88.4M | ||
| Q2 25 | $133.5M | $120.0M | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | $84.0M | ||
| Q3 24 | $163.1M | — | ||
| Q2 24 | $171.1M | $97.4M | ||
| Q1 24 | $-321.3M | — |
自由现金流ACHCRBC
| Q4 25 | $-179.5M | $99.1M | ||
| Q3 25 | $-63.0M | $71.7M | ||
| Q2 25 | $-34.2M | $104.3M | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | $73.6M | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | $88.4M | ||
| Q1 24 | $-463.7M | — |
自由现金流率ACHCRBC
| Q4 25 | -21.8% | 21.5% | ||
| Q3 25 | -7.4% | 15.7% | ||
| Q2 25 | -3.9% | 23.9% | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | 18.7% | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | 21.8% | ||
| Q1 24 | -60.4% | — |
资本支出强度ACHCRBC
| Q4 25 | 11.3% | 5.0% | ||
| Q3 25 | 16.0% | 3.7% | ||
| Q2 25 | 19.3% | 3.6% | ||
| Q1 25 | 22.7% | 3.2% | ||
| Q4 24 | 26.3% | 2.6% | ||
| Q3 24 | 23.3% | 4.1% | ||
| Q2 24 | 19.4% | 2.2% | ||
| Q1 24 | 18.5% | — |
现金转化率ACHCRBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | 2.02× | 1.47× | ||
| Q2 25 | 4.43× | 1.75× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 1.45× | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | 1.59× | ||
| Q1 24 | -4.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
